Integra Acquires French Group

In a move to supplement the company's surgical line, Integra Life Sciences Holding Corp. (Plainsboro, NJ, USA) has acquired the Newdeal group of companies (Lyon, France) for about U.S.$53 million in cash.

Newdeal is a leading developer and manufacturer of specialty implants for foot and ankle surgery. Its line includes a wide range of products for the forefoot, the mid-foot, and the hind foot, including the Bold screw, Hallu-Fix plate system, and the Hintegra total ankle prosthesis. The company sells its products through a direct sales force in France, Belgium, and the Netherlands, and through distributors in more than 30 countries. Target physicians are orthopedic surgeons and podiatric surgeons. The company name will not change as a result of the acquisition.

Integra Life Sciences develops and markets medical devices for neurotrauma and neurosurgery, plastic and reconstructive surgery, and general surgery. The company has manufacturing and research facilities throughout the world.

"We will supplement our direct sales force in Europe and increase revenues outside the United States,” said Stuart M. Essig, president and CEO of Integra Life Sciences. "We will work to integrate Newdeal into Integra so that the combined business can maximize the revenue synergies between our products.”


Related Links:
Integra Life Sciences